NOS3 and endothelial dysfunction: In experiments in ApoE-/-mouse models, liraglutide increased eNOS with significant improvement in endothelial function, and exendin-4 reversed the high-cholesterol diet-induced endothelial dysfunction through a GTP cyclohydrolase-1/tetrahydrobiopterin pathway [213,214].